The UK's burgeoning landscape of mind-altering substances is witnessing a remarkable shift, extending far outside the traditional concentration on psilocybin and LSD . Interest is currently centered on lesser-known compounds, like dimethyltryptamine, CBG a phytocannabinoid showing encouraging med